Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy

Eswari Dodagatta-Marri(University of California, San Francisco), Dean Sheppard(University of California, San Francisco)
Cell Reports
July 1, 2021
Cited by 67


Related Papers